The effect of single agent oral fusaric acid (FA) on the growth of subcuta neously xenografted SCC-1 cells in a nude mouse model
- 24 February 2006
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 24 (5) , 377-381
Abstract
Objective: To determine whether oral administration of fusaric acid (FA) inhibits tumor growth in an animal model of head and neck cancer (HNSCC). Design: In vivo murine model, two arm controlled study.Methods: Thirty-eight (38) 5-week-old athymic nude mice were randomly assigned to a fusaric acid treatment group (1 mg/mL) (n = 19) or a sterile saline group (n = 19). A left, lateral flank subcutaneous injection of 2.0 × 106 UM-SCC-1 cells were administered to all mice on day 1. Both groups were gavaged daily with either 0.25 mLs of oral FA or sterile saline throughout the experiment (32 days). Latency to a measurable tumor (≥65 mm3), and tumor volumes were recorded after tumor xenografting. Tumor weights were recorded at the conclusion of the experiment. Tumor volume growth curves were modeled as polynomial functions of time with treatment interaction effects. Survivorship functions for time to measurable tumor were estimated using the Kaplan-Meier product limit estimator. Results: Survival analysis showed mice treated with FA developed measurable tumors after a significantly longer interval post-xenografting than control mice (p = 0.00451). By Day 9, all mice in the control group had developed measurable tumors in comparison to only 78% of mice in the FA group. Likewise, estimated growth curves for both groups suggested that mice receiving FA demonstrated significantly slower tumor growth rates throughout the entire study period (p < 0.0001). At the conclusion of the experiment, tumor weights from both the control and FA groups were also significantly different (p = 0.0142). Conclusions: Single agent oral fusaric acid (1 mg/mL) is an inhibitor of UM-SCC-1 in a murine model. As an orally active agent, it may have a potential role in the treatment of human squamous cell carcinoma of the head and neck.Keywords
This publication has 14 references indexed in Scilit:
- Metallopanstimulin as a marker for head and neck cancerWorld Journal of Surgical Oncology, 2004
- A New Assay to Screen for Head and Neck Squamous cell Carcinoma Using the Tumor Marker MetallopanstimulinOtolaryngology–Head and Neck Surgery, 2004
- Fusaric acid: A novel agent and mechanism to treat HNSCCOtolaryngology–Head and Neck Surgery, 2004
- Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine ModelJAMA Otolaryngology–Head & Neck Surgery, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastomaInternational Journal of Cancer, 2002
- Apoptosis induced by Picolinic Acid-related Compounds in HL-60 CellsBioscience, Biotechnology, and Biochemistry, 2001
- Fusaric Acid and Modification of the Subchronic Toxicity to Rats of Fumonisins in F. moniliforme Culture MaterialFood and Chemical Toxicology, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- Iron: Possible cause of the G1 arrest induced in NRK cells by picolinic acidBiochemical and Biophysical Research Communications, 1977